Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

Nandita Vijayasimha, Bengaluru Thursday, February 13, 2025, 08:00 Hrs [IST] ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

With a 10% tariff making Chinese products costlier, US importers may turn to Indian companies as cost-effective alternatives.

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...